Sort
39,280 grants matching “leukemia”
Maternal Viral Infection and Fetal Brain Development
$307,210Paul H Patterson · California Institute Of Technology · R01 · FY2007 · MH
Maternal Viral Infection and Fetal Brain Development
$307,210Paul H Patterson · California Institute Of Technology · R01 · FY2008 · MH
Translational Investigation of KRas & NF1 in Myeloid Leukemia
$307,209Kevin M Shannon · University Of California, San Francisco · R37 · FY2009 · CA
Regulation of Innate Immune Responses
$307,202Glen N. Barber · University Of Miami School Of Medicine · P01 · FY2010 · CA
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
$307,181Michael A. Farrar · University Of Minnesota · R01 · FY2012 · CA
Repair of Genome Destabilizing DNA Structures
$307,161Karen M Vasquez · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Repair of Genome Destabilizing DNA Structures
$307,161Karen M Vasquez · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Repair of Genome Destabilizing DNA Structures
$307,161Karen M Vasquez · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
GENE EXPRESSION BY HUMAN GRANULOCYTIC EHRLICHIOSIS AG
$307,156Ohio State University · R01 · FY2001 · AI
NMR Studies of Retroviral Nucleic Acid Binding Proteins
$307,132Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2007 · GM
Genetic Analysis of Myeloproliferative Disease
$307,125John K Cowell · Augusta University · R01 · FY2015 · CA
MECHANISMS OF RETROVIRUS INDUCED T AND NEURAL CELL DEATH
$307,114University Of Texas Md Anderson Can Ctr · R01 · FY2002 · AI
Mechanisms of Metabolic Gene Mutations in Cancer
$307,100Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA
SWI/SNF complex loss facilitates gene silencing during NSCLC development
$307,100Bernard E. Weissman · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA
Mechanisms of Metabolic Gene Mutations in Cancer
$307,100Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
SWI/SNF complex loss facilitates gene silencing during NSCLC development
$307,100Bernard E. Weissman · Univ Of North Carolina Chapel Hill · R01 · FY2010 · CA
Molecular Analysis of Uterine Receptivity
$307,089Francesco John Demayo · Baylor College Of Medicine · R01 · FY2010 · HD
Development and Therapeutic Efficacy of a Novel Lactate Transporter inhibitor (MCT4) CB-202 in tumors that overexpress MCT4, such as Triple-Negative Breast Cancer (TNBC) and Acute Myeloid Leukemia (AL
$307,087Yong Wu · Charles R. Drew University Of Med & Sci · U54 · FY2025 · MD
Immunotherapy of B cell lymphoma with NK-T cells
$307,086Leonid S Metelitsa · Baylor College Of Medicine · P50 · FY2019 · CA
NPM/MLF1 IN LEUKEMIA AND NORMAL DEVELOPMENT
$307,062St. Jude Children'S Research Hospital · R01 · FY2001 · CA
Signal Transduction and Kinase Inhibition in CLL
$307,061Michael R Grever · University Of California, San Diego · P01 · FY2009 · CA
Mechanisms of Transcriptional Control by p300
$307,053Kevin Gardner · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
RBP2 regulation through differential recruitment to genomic loci
$307,042Elizaveta V Benevolenskaya · University Of Illinois At Chicago · R01 · FY2013 · CA
TRANSCRIPTION FACTOR REGULATION BY THE BCR/ABL ONCOGENE
$307,005Bruno Calabretta · Thomas Jefferson University · R01 · FY2006 · CA
Role of PHF6 in Normal Hematopoiesis and hematopoietic stem cell biology
$307,000Feng-Chun Yang · University Of Texas Hlth Science Center · R01 · FY2019 · HL